Selected research
Industry Research
Omega3 (Omega-3) Industry Research Report 2026
Market perspective
The global Omega3 (Omega-3) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Omega3 (Omega-3) market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Omega3 (Omega-3) market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Omega3 (Omega-3) market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Omega3 (Omega-3) include DSM, Skuny, Shandong Yuwang Pharmaceutical, BASF, Xinzhou, TASA, Solutex, Sinomega and Polaris, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Omega3 (Omega-3) market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Omega3 (Omega-3).
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Omega3 (Omega-3) Market by Company
DSM
Skuny
Shandong Yuwang Pharmaceutical
BASF
Xinzhou
TASA
Solutex
Sinomega
Polaris
Orkla Health
Omega Protein
OLVEA Fish Oils
Nippon Suisan Kaisha
Maruha Nichiro Foods
LYSI
Kinomega
KD Pharma(Marine Ingredients)
KD Pharma
Hofseth BioCare
Golden Omega
GC Rieber
EPAX
Croda
Bioprocess Algae
Auqi
Anti-Cancer
Omega3 (Omega-3) Segment by Type
Marine Source
Algae Source
Omega3 (Omega-3) Segment by Application
Pharmaceuticals
Infant Formula
Dietary Supplements
Fortified Food and Beverage
Pet Foods
Others
Omega3 (Omega-3) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Omega3 (Omega-3) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Omega3 (Omega-3) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Omega3 (Omega-3).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Omega3 (Omega-3) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Marine Source
- Algae Source
Applications
- Pharmaceuticals
- Infant Formula
- Dietary Supplements
- Fortified Food and Beverage
- Pet Foods
- Others
Companies covered
- DSM
- Skuny
- Shandong Yuwang Pharmaceutical
- BASF
- Xinzhou
- TASA
- Solutex
- Sinomega
- Polaris
- Orkla Health
- Omega Protein
- OLVEA Fish Oils
- Nippon Suisan Kaisha
- Maruha Nichiro Foods
- LYSI
- Kinomega
- KD Pharma(Marine Ingredients)
- KD Pharma
- Hofseth BioCare
- Golden Omega
- GC Rieber
- EPAX
- Croda
- Bioprocess Algae
- Auqi
- Anti-Cancer
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Omega3 (Omega-3) by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Marine Source
- 2.2.3 Algae Source
- 2.3 Omega3 (Omega-3) by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceuticals
- 2.3.3 Infant Formula
- 2.3.4 Dietary Supplements
- 2.3.5 Fortified Food and Beverage
- 2.3.6 Pet Foods
- 2.3.7 Others
- 2.4 Assumptions and Limitations
3 Omega3 (Omega-3) Breakdown Data by Type
- 3.1 Global Omega3 (Omega-3) Historic Market Size by Type (2021-2026)
- 3.2 Global Omega3 (Omega-3) Forecasted Market Size by Type (2027-2032)
4 Omega3 (Omega-3) Breakdown Data by Application
- 4.1 Global Omega3 (Omega-3) Historic Market Size by Application (2021-2026)
- 4.2 Global Omega3 (Omega-3) Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Omega3 (Omega-3) Market Perspective (2021-2032)
- 5.2 Global Omega3 (Omega-3) Growth Trends by Region
- 5.2.1 Global Omega3 (Omega-3) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Omega3 (Omega-3) Historic Market Size by Region (2021-2026)
- 5.2.3 Omega3 (Omega-3) Forecasted Market Size by Region (2027-2032)
- 5.3 Omega3 (Omega-3) Market Dynamics
- 5.3.1 Omega3 (Omega-3) Industry Trends
- 5.3.2 Omega3 (Omega-3) Market Drivers
- 5.3.3 Omega3 (Omega-3) Market Challenges
- 5.3.4 Omega3 (Omega-3) Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Omega3 (Omega-3) Players by Revenue
- 6.1.1 Global Top Omega3 (Omega-3) Players by Revenue (2021-2026)
- 6.1.2 Global Omega3 (Omega-3) Revenue Market Share by Players (2021-2026)
- 6.2 Global Omega3 (Omega-3) Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Omega3 (Omega-3) Head Office and Area Served
- 6.4 Global Omega3 (Omega-3) Players, Product Type & Application
- 6.5 Global Omega3 (Omega-3) Manufacturers Established Date
- 6.6 Global Omega3 (Omega-3) Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Omega3 (Omega-3) Market Size (2021-2032)
- 7.2 North America Omega3 (Omega-3) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Omega3 (Omega-3) Market Size by Country (2021-2026)
- 7.4 North America Omega3 (Omega-3) Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Omega3 (Omega-3) Market Size (2021-2032)
- 8.2 Europe Omega3 (Omega-3) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Omega3 (Omega-3) Market Size by Country (2021-2026)
- 8.4 Europe Omega3 (Omega-3) Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Omega3 (Omega-3) Market Size (2021-2032)
- 9.2 Asia-Pacific Omega3 (Omega-3) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Omega3 (Omega-3) Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Omega3 (Omega-3) Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Omega3 (Omega-3) Market Size (2021-2032)
- 10.2 South America Omega3 (Omega-3) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Omega3 (Omega-3) Market Size by Country (2021-2026)
- 10.4 South America Omega3 (Omega-3) Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Omega3 (Omega-3) Market Size (2021-2032)
- 11.2 Middle East & Africa Omega3 (Omega-3) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Omega3 (Omega-3) Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Omega3 (Omega-3) Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 DSM
- 12.1.1 DSM Company Information
- 12.1.2 DSM Business Overview
- 12.1.3 DSM Revenue in Omega3 (Omega-3) Business (2021-2026)
- 12.1.4 DSM Omega3 (Omega-3) Product Portfolio
- 12.1.5 DSM Recent Developments
- 12.2 Skuny
- 12.2.1 Skuny Company Information
- 12.2.2 Skuny Business Overview
- 12.2.3 Skuny Revenue in Omega3 (Omega-3) Business (2021-2026)
- 12.2.4 Skuny Omega3 (Omega-3) Product Portfolio
- 12.2.5 Skuny Recent Developments
- 12.3 Shandong Yuwang Pharmaceutical
- 12.3.1 Shandong Yuwang Pharmaceutical Company Information
- 12.3.2 Shandong Yuwang Pharmaceutical Business Overview
- 12.3.3 Shandong Yuwang Pharmaceutical Revenue in Omega3 (Omega-3) Business (2021-2026)
- 12.3.4 Shandong Yuwang Pharmaceutical Omega3 (Omega-3) Product Portfolio
- 12.3.5 Shandong Yuwang Pharmaceutical Recent Developments
- 12.4 BASF
- 12.4.1 BASF Company Information
- 12.4.2 BASF Business Overview
- 12.4.3 BASF Revenue in Omega3 (Omega-3) Business (2021-2026)
- 12.4.4 BASF Omega3 (Omega-3) Product Portfolio
- 12.4.5 BASF Recent Developments
- 12.5 Xinzhou
- 12.5.1 Xinzhou Company Information
- 12.5.2 Xinzhou Business Overview
- 12.5.3 Xinzhou Revenue in Omega3 (Omega-3) Business (2021-2026)
- 12.5.4 Xinzhou Omega3 (Omega-3) Product Portfolio
- 12.5.5 Xinzhou Recent Developments
- 12.6 TASA
- 12.6.1 TASA Company Information
- 12.6.2 TASA Business Overview
- 12.6.3 TASA Revenue in Omega3 (Omega-3) Business (2021-2026)
- 12.6.4 TASA Omega3 (Omega-3) Product Portfolio
- 12.6.5 TASA Recent Developments
- 12.7 Solutex
- 12.7.1 Solutex Company Information
- 12.7.2 Solutex Business Overview
- 12.7.3 Solutex Revenue in Omega3 (Omega-3) Business (2021-2026)
- 12.7.4 Solutex Omega3 (Omega-3) Product Portfolio
- 12.7.5 Solutex Recent Developments
- 12.8 Sinomega
- 12.8.1 Sinomega Company Information
- 12.8.2 Sinomega Business Overview
- 12.8.3 Sinomega Revenue in Omega3 (Omega-3) Business (2021-2026)
- 12.8.4 Sinomega Omega3 (Omega-3) Product Portfolio
- 12.8.5 Sinomega Recent Developments
- 12.9 Polaris
- 12.9.1 Polaris Company Information
- 12.9.2 Polaris Business Overview
- 12.9.3 Polaris Revenue in Omega3 (Omega-3) Business (2021-2026)
- 12.9.4 Polaris Omega3 (Omega-3) Product Portfolio
- 12.9.5 Polaris Recent Developments
- 12.10 Orkla Health
- 12.10.1 Orkla Health Company Information
- 12.10.2 Orkla Health Business Overview
- 12.10.3 Orkla Health Revenue in Omega3 (Omega-3) Business (2021-2026)
- 12.10.4 Orkla Health Omega3 (Omega-3) Product Portfolio
- 12.10.5 Orkla Health Recent Developments
- 12.11 Omega Protein
- 12.11.1 Omega Protein Company Information
- 12.11.2 Omega Protein Business Overview
- 12.11.3 Omega Protein Revenue in Omega3 (Omega-3) Business (2021-2026)
- 12.11.4 Omega Protein Omega3 (Omega-3) Product Portfolio
- 12.11.5 Omega Protein Recent Developments
- 12.12 OLVEA Fish Oils
- 12.12.1 OLVEA Fish Oils Company Information
- 12.12.2 OLVEA Fish Oils Business Overview
- 12.12.3 OLVEA Fish Oils Revenue in Omega3 (Omega-3) Business (2021-2026)
- 12.12.4 OLVEA Fish Oils Omega3 (Omega-3) Product Portfolio
- 12.12.5 OLVEA Fish Oils Recent Developments
- 12.13 Nippon Suisan Kaisha
- 12.13.1 Nippon Suisan Kaisha Company Information
- 12.13.2 Nippon Suisan Kaisha Business Overview
- 12.13.3 Nippon Suisan Kaisha Revenue in Omega3 (Omega-3) Business (2021-2026)
- 12.13.4 Nippon Suisan Kaisha Omega3 (Omega-3) Product Portfolio
- 12.13.5 Nippon Suisan Kaisha Recent Developments
- 12.14 Maruha Nichiro Foods
- 12.14.1 Maruha Nichiro Foods Company Information
- 12.14.2 Maruha Nichiro Foods Business Overview
- 12.14.3 Maruha Nichiro Foods Revenue in Omega3 (Omega-3) Business (2021-2026)
- 12.14.4 Maruha Nichiro Foods Omega3 (Omega-3) Product Portfolio
- 12.14.5 Maruha Nichiro Foods Recent Developments
- 12.15 LYSI
- 12.15.1 LYSI Company Information
- 12.15.2 LYSI Business Overview
- 12.15.3 LYSI Revenue in Omega3 (Omega-3) Business (2021-2026)
- 12.15.4 LYSI Omega3 (Omega-3) Product Portfolio
- 12.15.5 LYSI Recent Developments
- 12.16 Kinomega
- 12.16.1 Kinomega Company Information
- 12.16.2 Kinomega Business Overview
- 12.16.3 Kinomega Revenue in Omega3 (Omega-3) Business (2021-2026)
- 12.16.4 Kinomega Omega3 (Omega-3) Product Portfolio
- 12.16.5 Kinomega Recent Developments
- 12.17 KD Pharma(Marine Ingredients)
- 12.17.1 KD Pharma(Marine Ingredients) Company Information
- 12.17.2 KD Pharma(Marine Ingredients) Business Overview
- 12.17.3 KD Pharma(Marine Ingredients) Revenue in Omega3 (Omega-3) Business (2021-2026)
- 12.17.4 KD Pharma(Marine Ingredients) Omega3 (Omega-3) Product Portfolio
- 12.17.5 KD Pharma(Marine Ingredients) Recent Developments
- 12.18 KD Pharma
- 12.18.1 KD Pharma Company Information
- 12.18.2 KD Pharma Business Overview
- 12.18.3 KD Pharma Revenue in Omega3 (Omega-3) Business (2021-2026)
- 12.18.4 KD Pharma Omega3 (Omega-3) Product Portfolio
- 12.18.5 KD Pharma Recent Developments
- 12.19 Hofseth BioCare
- 12.19.1 Hofseth BioCare Company Information
- 12.19.2 Hofseth BioCare Business Overview
- 12.19.3 Hofseth BioCare Revenue in Omega3 (Omega-3) Business (2021-2026)
- 12.19.4 Hofseth BioCare Omega3 (Omega-3) Product Portfolio
- 12.19.5 Hofseth BioCare Recent Developments
- 12.20 Golden Omega
- 12.20.1 Golden Omega Company Information
- 12.20.2 Golden Omega Business Overview
- 12.20.3 Golden Omega Revenue in Omega3 (Omega-3) Business (2021-2026)
- 12.20.4 Golden Omega Omega3 (Omega-3) Product Portfolio
- 12.20.5 Golden Omega Recent Developments
- 12.21 GC Rieber
- 12.21.1 GC Rieber Company Information
- 12.21.2 GC Rieber Business Overview
- 12.21.3 GC Rieber Revenue in Omega3 (Omega-3) Business (2021-2026)
- 12.21.4 GC Rieber Omega3 (Omega-3) Product Portfolio
- 12.21.5 GC Rieber Recent Developments
- 12.22 EPAX
- 12.22.1 EPAX Company Information
- 12.22.2 EPAX Business Overview
- 12.22.3 EPAX Revenue in Omega3 (Omega-3) Business (2021-2026)
- 12.22.4 EPAX Omega3 (Omega-3) Product Portfolio
- 12.22.5 EPAX Recent Developments
- 12.23 Croda
- 12.23.1 Croda Company Information
- 12.23.2 Croda Business Overview
- 12.23.3 Croda Revenue in Omega3 (Omega-3) Business (2021-2026)
- 12.23.4 Croda Omega3 (Omega-3) Product Portfolio
- 12.23.5 Croda Recent Developments
- 12.24 Bioprocess Algae
- 12.24.1 Bioprocess Algae Company Information
- 12.24.2 Bioprocess Algae Business Overview
- 12.24.3 Bioprocess Algae Revenue in Omega3 (Omega-3) Business (2021-2026)
- 12.24.4 Bioprocess Algae Omega3 (Omega-3) Product Portfolio
- 12.24.5 Bioprocess Algae Recent Developments
- 12.25 Auqi
- 12.25.1 Auqi Company Information
- 12.25.2 Auqi Business Overview
- 12.25.3 Auqi Revenue in Omega3 (Omega-3) Business (2021-2026)
- 12.25.4 Auqi Omega3 (Omega-3) Product Portfolio
- 12.25.5 Auqi Recent Developments
- 12.26 Anti-Cancer
- 12.26.1 Anti-Cancer Company Information
- 12.26.2 Anti-Cancer Business Overview
- 12.26.3 Anti-Cancer Revenue in Omega3 (Omega-3) Business (2021-2026)
- 12.26.4 Anti-Cancer Omega3 (Omega-3) Product Portfolio
- 12.26.5 Anti-Cancer Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst